Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

The combined therapy improved symptoms in PCOS patients.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

New treatments aim to improve thin endometrium to help more couples with infertility.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Testosterone reduces key molecules needed for early pregnancy in rats.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

PCOS symptoms vary by age, affecting diagnosis and treatment.

PCOS may increase eye pressure and corneal thickness, affecting eye health.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common side effect of hormone treatments for cancer.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

The new bariatric surgery SAGI PGP is effective for weight loss and diabetes control with few complications.

Raising awareness about PCOS can improve women's quality of life.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.